VERQUVO
- Product NDC
- 0006-5030
- 11-digit product format
- 000065030
- Labeler code
- 0006
- Product ID
- 0006-5030_13b78d9a-fa62-4fcf-8a33-233bc48faccb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- vericiguat
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Merck Sharp & Dohme LLC
- Application
- NDA214377
- Marketing category
- NDA
- Marketing start
- 2021-02-01
- Substance
- VERICIGUAT
- Active strength
- 10 mg/1
- Pharmacologic classes
- Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- VERQUVO
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| VERICIGUAT | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LV66ADM269 |
| Rxcui | 2475846, 2475852, 2475854, 2475856, 2475858, 2475860 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 0006-5030-01 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64a7-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VERQUVO safely and effectively. See full prescribing information for VERQUVO. VERQUVO ® (vericiguat) tablets, for oral use Initial U.S. Approval: 2021 |
| 0006-5030-01 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64a7-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VERQUVO safely and effectively. See full prescribing information for VERQUVO. VERQUVO ® (vericiguat) tablets, for oral use Initial U.S. Approval: 2021 |
| 0006-5030-01 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64a7-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VERQUVO safely and effectively. See full prescribing information for VERQUVO. VERQUVO ® (vericiguat) tablets, for oral use Initial U.S. Approval: 2021 |
| 0006-5030-02 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64a7-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VERQUVO safely and effectively. See full prescribing information for VERQUVO. VERQUVO ® (vericiguat) tablets, for oral use Initial U.S. Approval: 2021 |
| 0006-5030-02 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64a7-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VERQUVO safely and effectively. See full prescribing information for VERQUVO. VERQUVO ® (vericiguat) tablets, for oral use Initial U.S. Approval: 2021 |
| 0006-5030-02 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64a7-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VERQUVO safely and effectively. See full prescribing information for VERQUVO. VERQUVO ® (vericiguat) tablets, for oral use Initial U.S. Approval: 2021 |
| 0006-5030-04 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64a7-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VERQUVO safely and effectively. See full prescribing information for VERQUVO. VERQUVO ® (vericiguat) tablets, for oral use Initial U.S. Approval: 2021 |
| 0006-5030-04 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64a7-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VERQUVO safely and effectively. See full prescribing information for VERQUVO. VERQUVO ® (vericiguat) tablets, for oral use Initial U.S. Approval: 2021 |
| 0006-5030-04 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64a7-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VERQUVO safely and effectively. See full prescribing information for VERQUVO. VERQUVO ® (vericiguat) tablets, for oral use Initial U.S. Approval: 2021 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0006-5030-01 | VERQUVO | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 13 |
| 0006-5030-02 | VERQUVO | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 13 |
| 0006-5030-03 | VERQUVO | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | | 13 |
| 0006-5030-04 | VERQUVO | 10 in 1 CARTON | TABLET, FILM COATED | 10 | | 13 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0006-5030 | VERQUVO (VERICIGUAT) TABLET, FILM COATED [MERCK SHARP & DOHME LLC] | 10 | Current NDC, Legacy NDC, 4 package rows | 20241116_17056d73-1b1b-4bf2-9c07-b7a9367f0d6d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0006-5030-01 | 00006503001 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-5030-01) | | 2021-02-01 | 0000-00-00 | No | No | Current |
| 0006-5030-02 | 00006503002 | 90 TABLET, FILM COATED in 1 BOTTLE (0006-5030-02) | | 2021-02-01 | 0000-00-00 | No | No | Current |
| 0006-5030-03 | 00006503003 | 10 BLISTER PACK in 1 CARTON (0006-5030-03) > 10 TABLET, FILM COATED in 1 BLISTER PACK | 10 blister pack | 2021-02-01 | 0000-00-00 | No | No | Current |
| 0006-5030-04 | 00006503004 | 10 BLISTER PACK in 1 CARTON (0006-5030-04) / 10 TABLET, FILM COATED in 1 BLISTER PACK (0006-5030-03) | 10 blister pack | 2021-02-01 | | No | No | Current |